Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00767221
What this trial is testing

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

Who this might be right for
IGA Nephropathy
Calliditas Therapeutics AB 20
Large-scale testing (Phase 3)Study completedNCT02232776
What this trial is testing

Efficacy and Safety of Losartan in Children With Ig A Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Seoul National University Hospital 37
Early research (Phase 1)Study completedNCT03719443
What this trial is testing

First in Human Study to Assess Safety of VIS649 in Healthy Subjects

Who this might be right for
Immunoglobulin A NephropathyIgAN - IgA NephropathyIgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 51
Not applicableUnknownNCT03054545
What this trial is testing

Iguratimod as Treatment for Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
RenJi Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868838
What this trial is testing

Daratumumab to Treat Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Mayo Clinic 12
Testing effectiveness (Phase 2)Ended earlyNCT04387448
What this trial is testing

TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Who this might be right for
Kidney DiseasesDiabetic NephropathiesGlomerulosclerosis, Focal Segmental+8 more
Goldfinch Bio, Inc. 96
Not applicableNot Yet RecruitingNCT06792448
What this trial is testing

Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study

Who this might be right for
Nephrotic Syndrome Steroid-DependentNephrotic Syndrome Steroid-ResistantNephrotic Syndrome in Children+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 350
Post-approval studies (Phase 4)WithdrawnNCT02382523
What this trial is testing

Acthar on Proteinuria in IgA Nephropathy Patients

Who this might be right for
IgA NephropathyProteinuria
Baylor College of Medicine
Testing effectiveness (Phase 2)Study completedNCT02000440
What this trial is testing

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Glomerulosclerosis, Focal Segmental
GlaxoSmithKline 17
Testing effectiveness (Phase 2)UnknownNCT03917797
What this trial is testing

Mesenchymal Stromal Cells (MSC´s) in Renal Lupus

Who this might be right for
Lupus Erythematosus, SystemicLupus Glomerulonephritis
Universidad de los Andes, Chile 39
Not applicableUnknownNCT03526042
What this trial is testing

Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis

Who this might be right for
AtherosclerosisLupus Nephritis
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 40
Testing effectiveness (Phase 2)Study completedNCT03366337
What this trial is testing

Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Who this might be right for
IgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more
Biogen 103
Not applicableUnknownNCT06520670
What this trial is testing

Urinary G3BP as a Novel Biomarker in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 70
Not applicableUnknownNCT05845151
What this trial is testing

Fibroblast Activating Protein Inhibitor PET Imaging in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Ruijin Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06635772
What this trial is testing

The Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

Who this might be right for
Immunoglobulin a Nephropathy
Hansoh BioMedical R&D Company 90
Not applicableUnknownNCT06428539
What this trial is testing

T Regulatory Cells IN LUPUS NEPHRITIS

Who this might be right for
Lupus Nephritis
Assiut University 65
Post-approval studies (Phase 4)UnknownNCT00862693
What this trial is testing

Calcitriol in the Treatment of Immunoglobulin A Nephropathy

Who this might be right for
GlomerulonephritisAutoimmune Diseases
Peking University First Hospital 40
Not applicableStudy completedNCT07617402
What this trial is testing

Exploring the Brain - Gut Microbiota - Kidney Interactive Damage Mechanisms Underlying Cognitive Decline in Patients With IgA Nephropathy Using Ultra-high Field Magnetic Resonance Imaging

Who this might be right for
IgA Nephropathy (IgAN)
Tang-Du Hospital 200
Testing effectiveness (Phase 2)Study completedNCT04572854
What this trial is testing

Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN

Who this might be right for
C3GIC-MPGNRenal Transplant+9 more
Apellis Pharmaceuticals, Inc. 13
Not applicableStudy completedNCT00004305
What this trial is testing

Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis

Who this might be right for
IGA Glomerulonephritis
National Center for Research Resources (NCRR) 105
Next Page